These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 36320041)

  • 61. Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis.
    Yang T; Yao Q; Cao F; Liu Q; Liu B; Wang XH
    Int J Nanomedicine; 2016; 11():6679-6692. PubMed ID: 27994464
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Methylalpinumisoflavone inhibits hypoxia-inducible factor-1 (HIF-1) activation by simultaneously targeting multiple pathways.
    Liu Y; Veena CK; Morgan JB; Mohammed KA; Jekabsons MB; Nagle DG; Zhou YD
    J Biol Chem; 2009 Feb; 284(9):5859-68. PubMed ID: 19091749
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeting tumor angiogenesis with histone deacetylase inhibitors.
    Ellis L; Hammers H; Pili R
    Cancer Lett; 2009 Aug; 280(2):145-53. PubMed ID: 19111391
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole.
    Pourgholami MH; Cai ZY; Badar S; Wangoo K; Poruchynsky MS; Morris DL
    BMC Cancer; 2010 Apr; 10():143. PubMed ID: 20398289
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
    Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
    Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation of galectins by hypoxia and their relevance in angiogenesis: strategies and methods.
    Salatino M; Croci DO; Laderach DJ; Compagno D; Gentilini L; Dalotto-Moreno T; Dergan-Dylon LS; Méndez-Huergo SP; Toscano MA; Cerliani JP; Rabinovich GA
    Methods Mol Biol; 2015; 1207():293-304. PubMed ID: 25253148
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.
    Nam SY; Ko YS; Jung J; Yoon J; Kim YH; Choi YJ; Park JW; Chang MS; Kim WH; Lee BL
    Br J Cancer; 2011 Jan; 104(1):166-74. PubMed ID: 21119667
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies.
    Qiu GZ; Jin MZ; Dai JX; Sun W; Feng JH; Jin WL
    Trends Pharmacol Sci; 2017 Aug; 38(8):669-686. PubMed ID: 28602395
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
    Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of hypoxia inducible factor-1α downregulates the expression of epithelial to mesenchymal transition early marker proteins without undermining cell survival in hypoxic lens epithelial cells.
    Cammarata PR; Neelam S; Brooks MM
    Mol Vis; 2015; 21():1024-35. PubMed ID: 26392741
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition.
    Jampasri S; Reabroi S; Tungmunnithum D; Parichatikanond W; Pinthong D
    Molecules; 2022 Sep; 27(17):. PubMed ID: 36080483
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α.
    Kim YJ; Lee HJ; Kim TM; Eisinger-Mathason TS; Zhang AY; Schmidt B; Karl DL; Nakazawa MS; Park PJ; Simon MC; Yoon SS
    Int J Cancer; 2013 Jan; 132(1):29-41. PubMed ID: 22684860
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts.
    Tuomela J; Grönroos TJ; Valta MP; Sandholm J; Schrey A; Seppänen J; Marjamäki P; Forsback S; Kinnunen I; Solin O; Minn H; Härkönen PL
    BMC Cancer; 2010 Oct; 10():596. PubMed ID: 21034500
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multifunctional albumin-MnO₂ nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response.
    Prasad P; Gordijo CR; Abbasi AZ; Maeda A; Ip A; Rauth AM; DaCosta RS; Wu XY
    ACS Nano; 2014 Apr; 8(4):3202-12. PubMed ID: 24702320
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
    Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
    Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 77. TNF-α upregulates HIF-1α expression in pterygium fibroblasts and enhances their susceptibility to VEGF independent of hypoxia.
    Kim KW; Lee SJ; Kim JC
    Exp Eye Res; 2017 Nov; 164():74-81. PubMed ID: 28803935
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions.
    Zhang TQ; Lv QY; Jin WL
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189137. PubMed ID: 38880161
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
    Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
    Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia.
    Nalini D; Selvaraj J; Kumar GS
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):1-18. PubMed ID: 31724069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.